| Drug Name: | Prenylamine (390-64-7) |
|---|---|
| PubChem ID: | 9801 |
| SMILES: | CC(CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3 |
| InchiKey: | IFFPICMESYHZPQ-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Calcium Channel Blockers, Cardiovascular Agents, Membrane Transport Modulators, Neurotransmitter Agents, Vasodilator Agents |
| Molecular Weight (dalton) | : | 329.487 |
| LogP | : | 5.4294 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 12.03 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Myocardial Infarction | Sodium-dependent dopamine transporter (Q01959) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Sedation | Beta-1 adrenergic receptor (P18090) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category